$1.53 Billion is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 117 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NAVG | Exit | NAVIGATORS GROUP INC | $0 | – | -696 | -100.0% | -0.00% | – |
| CARA | Exit | CARA THERAPEUTICS INCcall | $0 | – | -16,500 | -100.0% | -0.02% | – |
| TNXP | Exit | TONIX PHARMACEUTICALS HLDG C | $0 | – | -64,549 | -100.0% | -0.02% | – |
| JAGX | Exit | JAGUAR ANIMAL HEALTH INC | $0 | – | -1,297,815 | -100.0% | -0.05% | – |
| UA | Exit | UNDER ARMOUR INCcl c | $0 | – | -82,169 | -100.0% | -0.11% | – |
| BUFF | Exit | BLUE BUFFALO PET PRODS INC | $0 | – | -75,000 | -100.0% | -0.12% | – |
| VSAR | Exit | VERSARTIS INC | $0 | – | -117,043 | -100.0% | -0.14% | – |
| ENTL | Exit | ENTELLUS MED INC | $0 | – | -124,866 | -100.0% | -0.14% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB COput | $0 | – | -50,000 | -100.0% | -0.19% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -50,000 | -100.0% | -0.19% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DELcall | $0 | – | -649,000 | -100.0% | -0.20% | – |
| ATRS | Exit | ANTARES PHARMA INC | $0 | – | -946,987 | -100.0% | -0.21% | – |
| MYL | Exit | MYLAN N Vput | $0 | – | -99,800 | -100.0% | -0.26% | – |
| GEC | Exit | GREAT ELM CAP GROUP INC | $0 | – | -1,267,205 | -100.0% | -0.29% | – |
| AMZN | Exit | AMAZON COM INC | $0 | – | -5,278 | -100.0% | -0.35% | – |
| SC | Exit | SANTANDER CONSUMER USA HDG I | $0 | – | -403,657 | -100.0% | -0.35% | – |
| MDLZ | Exit | MONDELEZ INTL INCcl a | $0 | – | -120,506 | -100.0% | -0.36% | – |
| Exit | INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 | $0 | – | -9,700,000 | -100.0% | -0.40% | – | |
| OTIC | Exit | OTONOMY INC | $0 | – | -312,453 | -100.0% | -0.40% | – |
| WAB | Exit | WABTEC CORP | $0 | – | -73,800 | -100.0% | -0.46% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INCput | $0 | – | -124,800 | -100.0% | -0.48% | – |
| ETFC | Exit | E TRADE FINANCIAL CORP | $0 | – | -190,873 | -100.0% | -0.50% | – |
| YUM | Exit | YUM BRANDS INC | $0 | – | -106,830 | -100.0% | -0.54% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INCcall | $0 | – | -499,200 | -100.0% | -0.56% | – |
| LNC | Exit | LINCOLN NATL CORP IND | $0 | – | -146,766 | -100.0% | -0.68% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -62,935 | -100.0% | -0.71% | – |
| CSX | Exit | CSX CORP | $0 | – | -194,694 | -100.0% | -0.73% | – |
| CMA | Exit | COMERICA INC | $0 | – | -148,401 | -100.0% | -0.74% | – |
| LNG | Exit | CHENIERE ENERGY INC | $0 | – | -253,821 | -100.0% | -0.84% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG COput | $0 | – | -199,700 | -100.0% | -0.87% | – |
| MDLZ | Exit | MONDELEZ INTL INCcall | $0 | – | -299,500 | -100.0% | -0.88% | – |
| GPORQ | Exit | GULFPORT ENERGY CORP | $0 | – | -1,080,280 | -100.0% | -1.09% | – |
| CL | Exit | COLGATE PALMOLIVE COcall | $0 | – | -249,600 | -100.0% | -1.26% | – |
| IP | Exit | INTL PAPER CO | $0 | – | -355,817 | -100.0% | -1.38% | – |
| Exit | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $0 | – | -27,250,000 | -100.0% | -1.60% | – | |
| WDC | Exit | WESTERN DIGITAL CORP | $0 | – | -296,651 | -100.0% | -1.80% | – |
| MLM | Exit | MARTIN MARIETTA MATLS INC | $0 | – | -122,931 | -100.0% | -1.87% | – |
| NTRS | Exit | NORTHERN TR CORP | $0 | – | -312,498 | -100.0% | -2.08% | – |
| IBB | Exit | ISHARES TRput | $0 | – | -99,800 | -100.0% | -2.12% | – |
| DOW | Exit | DOW CHEM CO | $0 | – | -693,782 | -100.0% | -2.99% | – |
| HYG | Exit | ISHARES TRput | $0 | – | -500,000 | -100.0% | -3.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.